WHO updates global guidance on medicines, diagnostic tests
(WorldNews Health)

The World Health Organisation (WHO) has updated global guidance on medicines and diagnostic tests to address health challenges, prioritise highly effective therapeutics, and improve affordable access. The two lists focused on cancer and other global health challenges, with an emphasis on effective solutions, smart prioritization, and optimal access for patients. The two recently developed immunotherapies (nivolumab and pembrolizumab), WHO say, have delivered up to 50 per cent survival rates for advanced melanoma, a cancer...